Dr. Erica L. Mayer, MD MPH
Claim this profileDana-Farber Cancer Institute
Area of expertise
Breast Cancer
Erica L. Mayer, MD MPH has run 8 trials for Breast Cancer. Some of their research focus areas include:
BRCA1 Mutation
Erica L. Mayer, MD MPH has run 1 trial for BRCA1 Mutation. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber Cancer Institute
Dana Farber Cancer Institute (Data Collection Only)
Clinical Trials Erica L. Mayer, MD MPH is currently running
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting
1 award
Phase 2
18 criteria
Avelumab + Palbociclib/Hydroxychloroquine
for Breast Cancer
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor disseminated tumor cells (DTCs) in the bone marrow after definitive surgery and standard adjuvant therapy.
Recruiting
3 awards
Phase 2
12 criteria
More about Erica L. Mayer, MD MPH
Clinical Trial Related
5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Erica L. Mayer, MD MPH has experience with
- Palbociclib
- Avelumab
- Exemestane
- Standard Adjuvant Endocrine Therapy
- Abemaciclib
- Anastrozole/Letrozole
Breakdown of trials Erica L. Mayer, MD MPH has run
Breast Cancer
BRCA1 Mutation
BRCA2 Mutation
PALB2 Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erica L. Mayer, MD MPH specialize in?
Erica L. Mayer, MD MPH focuses on Breast Cancer and BRCA1 Mutation. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are HER2 negative.
Is Erica L. Mayer, MD MPH currently recruiting for clinical trials?
Yes, Erica L. Mayer, MD MPH is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Erica L. Mayer, MD MPH has studied deeply?
Yes, Erica L. Mayer, MD MPH has studied treatments such as Palbociclib, Avelumab, Exemestane.
What is the best way to schedule an appointment with Erica L. Mayer, MD MPH?
Apply for one of the trials that Erica L. Mayer, MD MPH is conducting.
What is the office address of Erica L. Mayer, MD MPH?
The office of Erica L. Mayer, MD MPH is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.